Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, FCT17.6000, Houston, TX 77030, USA.
Expert Rev Anticancer Ther. 2014 Aug;14(8):919-29. doi: 10.1586/14737140.2014.919860. Epub 2014 May 16.
Traditionally, pancreatic ductal adenocarcinoma with regional vascular involvement was thought to represent unresectable disease and was associated with disease progression and death within 1 year of diagnosis. Recent evidence demonstrates that pancreaticoduodenectomy with vascular resection and reconstruction can be safely performed in select patients with 5-year survival rates as high as 20%. In order to safely treat and to optimize survival in these complex patients, it is essential to accurately identify vascular involvement preoperatively, to utilize a multidisciplinary treatment approach, and to emphasize meticulous surgical technique with awareness of the critical margins of resection.
传统上,伴有区域性血管侵犯的胰腺导管腺癌被认为是不可切除的疾病,与诊断后 1 年内疾病进展和死亡相关。最近的证据表明,在选择的患者中安全地进行胰十二指肠切除术联合血管切除和重建,可以获得高达 20%的 5 年生存率。为了安全地治疗这些复杂患者并优化其生存,术前准确识别血管侵犯、采用多学科治疗方法以及强调精细的手术技术并注意关键的切除边界至关重要。